Research Articles | Page 9 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide Apr 2020 Blood Advances Aplastic Anemia
Statin Use in Myelodysplastic Syndromes Is Associated with a Better Survival and Decreased Progression to Leukemia Apr 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia Oct 2019 Blood Advances Aplastic Anemia
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes Apr 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years Oct 2019 Blood Advances Aplastic Anemia
Guideline-based indicators for adult patients with myelodysplastic syndromes Aug 2020 Blood Advances Myelodysplastic Syndromes (MDS)
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Jul 2020 Blood Advances Myelodysplastic Syndromes (MDS)
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes Feb 2021 Blood Advances Myelodysplastic Syndromes (MDS)